Received Oct 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EW0150 | SYR / RA |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EW0150 | OT |
Extreme fatigue; developed gradually balance problem; tremor; This is a spontaneous report received from a Consumer or other non HCP. An elderly female patient received BNT162b2 (BNT162B2), on 12Apr2021 as dose 1, single (Lot number: EW0150) at the age of 75 years intramuscular, in arm for covid-19 immunisation. The patient had no relevant medical history. There were no other diagnosed illnesses/medical history/chronic health conditions to report. The patient is not allergic to any previous vaccination, medications, food or other products. There were no concomitant medications. The following information was reported: FATIGUE (disability), outcome "not recovered", described as "Extreme fatigue"; BALANCE DISORDER (non-serious), outcome "unknown", described as "developed gradually balance problem"; TREMOR (non-serious), outcome "unknown". The event "extreme fatigue" required physician office visit.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500107080 same patient/suspect vaccine; different dose/event;
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None